The value of drugs procured through China's national medical insurance information platform totaled nearly CNY1.05 trillion (USD156 billion) in 2025, up 5% year on year, according to the National Healthcare Security Administration. Of that, those procured through negotiations reached CNY172.5 billion, a 48% increase.